In the UK, where Abbott has been operating for more than 75 years, AbbVie employs 400 people (from a global workforce of 21,000).
Matt has 19 years’ experience in the pharma industry and was previously general manager, Abbott Pharmaceuticals in Norway.
AbbVie’s long-term growth will be fuelled by a compelling global pipeline of more than 20 mid- to late-stage clinical programmes.
AbbVie has tripled the number of new molecular entities in its pipeline over the last several years.
